Development of a Core Outcomes Set for Clinical Trials in Inflammatory Bowel Disease: An International Collaboration

炎症性肠病临床试验核心成果集的制定：国际合作

• 批准号: 363813
• 负责人: Ma Christopher
• 金额: $ 4.01万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-11-01 至 2018-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=363813&lang=en
• 关键词: Clinical Trials; Core Outcome Sets; Crohn'S Disease; Delphi Method; Inflammatory Bowel Disease; Ulcerative Colitis

Inflammatory bowel disease (IBD) affects 233,000 Canadians. IBD is a lifelong disease without a cure: patients suffer debilitating bowel symptoms, reduced quality of life, and impaired work capacity. 30% of patients do not respond to current medications b

炎症性肠病 (IBD) 影响着 233,000 名加拿大人。 IBD 是一种无法治愈的终生疾病：患者会出现肠道症状虚弱、生活质量下降和工作能力受损。 30% 的患者对当前药物没有反应 b